Synaptogenix Inc is a biopharmaceutical company focused on the discovery and development of innovative therapies aimed at treating neurodegenerative disorders, particularly diseases that affect cognitive function. The company specializes in proprietary formulations and advanced drug delivery systems designed to enhance synaptic health and promote neuronal survival. Through its research initiatives, Synaptogenix seeks to address unmet medical needs in conditions such as Alzheimer's disease and other forms of dementia, working towards improving the quality of life for affected individuals. Read More
Shares of NVIDIA Corporation (NASDAQ: NVDA) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for the first quarter.
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion. AMD shares dipped 3.8% to $165.49 on Wednesday.
Shares of Sintx Technologies, Inc. (NASDAQ: SINT) rose sharply in today’s pre-market trading after the company announced its subsidiary Technology Assessment & Transfer entered into a Cooperative Research and Development agreement with the U.S.
